Abbvie Limited

Lobbying Organisation Abbvie Limited

Date published 21 Sep, 2018

Relevant Matter Legislation

Public Policy Area Economic Development and Industry

Period 1 May, 2018 to 31 Aug, 2018

Specific Details To present the EY-DKM report on the importance of a robust IP framework to the Pharmaceutical Industry along with the Trade Associations submission to the public consultation on the EU SPC Waiver proposal

Intended results To advocate for safeguards in the proposed change to IP legislation in Europe

Name of person primarily responsible for lobbying on this activity Todd Manning; Paula Guerin

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Meeting with the MEP Mairead McGuinness and the Irish Pharmaceutical Trade Association (IPHA) to present the findings of a new EY-DKM report and outline the Pharma Industry's recommendations for safeguards in the proposed new legislation for an SPC Waiver

Email (2-5)

Emails pre and post the meeting with information on the agenda and a summary of the topics discussed.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Mairead McGuinness MEP (European Parliament)